Furthermore, overall survival analysis based on UALCAN revealed that high expression levels of EGFR, FLT1, PLG, EDN1, CLCN5, and ABCB1 were associated with worse survival of ccRCC patients. The gene discussed is CLCN5; the disease is nonpapillary renal cell carcinoma.